Stockreport

JMP Sees Big Gains in Rapport Therapeutics, Inc. (RAPP) After Focal Epilepsy Study Success [Yahoo! Finance]

Rapport Therapeutics, Inc.  (RAPP) 
PDF their ‘Market Outperform' rating on Rapport Therapeutics, Inc. (NASDAQ:RAPP) with a price target of $77, implying a potential surge of about 174%. This announcement foll [Read more]